MGH-17884-92107
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 461 / IN
- Registered
- 2021-05-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-21
Registered in v-safe
-
2021-05-21
Dose 1 — Moderna
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-26
- 2021-05-27
- 2021-05-28
- 2021-06-04
- 2021-06-11
-
2021-06-18
Dose 2 — Moderna
- 2021-06-18
- 2021-06-19
- 2021-06-20
- 2021-06-21
- 2021-06-22
- 2021-06-24
- 2021-06-27
- 2021-07-02
- 2021-07-09
- 2021-07-16
- 2021-07-25
- 2021-07-30
- 2021-09-17
- 2021-12-17
-
2021-12-20
Dose 3 — Moderna
- 2021-12-20
-
2021-12-21
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain · Headache, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-01-17
- 2022-01-24
- 2022-01-31
- 2022-03-23
-
2022-06-20
Survey response — 6 months, dose 3MedDRA: Arthralgia, Chills, Cough, Dyspnoea, Fatigue, Myalgia, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, chills, cough, trouble breathing, fatigue, muscle and joint pain, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-20
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-21
-
2022-06-21
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-21 | Moderna | |
| 2 | 2021-06-18 | Moderna | |
| 3 | 2021-12-20 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Release 12 — 6 months, dose 3
Symptoms: Fever, chills, cough, trouble breathing, fatigue, muscle and joint pain, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release